Company Announcement Avecho’s Phase III Clinical Trial for Insomnia Commences March 26, 2024March 26, 2024
Company Announcement Avecho completes meeting with TGA confirming pathway for Phase III Clinical Trial March 14, 2024March 14, 2024
Company Announcement Ethics Approval for amendments to Phase III Clinical Trial March 7, 2024March 7, 2024
Company Announcement Avecho reaches two-year stability milestone for its CBD softgel capsule June 22, 2023June 22, 2023
Company Announcement Avecho licenses TPM® for development of enhanced cancer drugs May 22, 2023May 22, 2023
Company Announcement Avecho commences CBD softgel manufacturing for pivotal Phase III insomnia study May 17, 2023May 17, 2023
Company Announcement Company Report Quarterly Activities Report and 4C – to 31 March 2023 April 28, 2023May 20, 2023
